GATA4 mutations are a cause of neonatal and childhood-onset diabetes.

No Thumbnail Available
Authors
Shaw-Smith, Charles
De Franco, Elisa
Lango Allen, H.
Batlle, M.
Flanagan, Sarah
Borowiec, M.
Taplin, C. E.
van Alfen-van der Velden, J.
Cruz-Rojo, J.
Perez de Nanclares, G.
Journal
Diabetes
Type
Journal Article
Research Support, Non-U.S. Gov't
Publisher
American Diabetes Association
Rights
Archived with thanks to Diabetes
The GATA family zinc finger transcription factors GATA4 and GATA6 are known to play important roles in the development of the pancreas. In mice, both Gata4 and Gata6 are required for pancreatic development. In humans, GATA6 haploinsufficiency can cause pancreatic agenesis and heart defects. Congenital heart defects also are common in patients with GATA4 mutations and deletions, but the role of GATA4 in the developing human pancreas is unproven. We report five patients with deletions (n = 4) or mutations of the GATA4 gene who have diabetes and a variable exocrine phenotype. In four cases, diabetes presented in the neonatal period (age at diagnosis 1-7 days). A de novo GATA4 missense mutation (p.N273K) was identified in a patient with complete absence of the pancreas confirmed at postmortem. This mutation affects a highly conserved residue located in the second zinc finger domain of the GATA4 protein. In vitro studies showed reduced DNA binding and transactivational activity of the mutant protein. We show that GATA4 mutations/deletions are a cause of neonatal or childhood-onset diabetes with or without exocrine insufficiency. These results confirm a role for GATA4 in normal development of the human pancreas.
Citation
GATA4 mutations are a cause of neonatal and childhood-onset diabetes. 2014, 63 (8):2888-94 Diabetes
Note